death semaglutide Semaglutide lowers risk of kidney failure and cardiovascular death in patients with type 2 diabetes and CKD, study results show

Recent study at UC Irvine found that semaglutide medication may benefit 93 million U.S. adults

20.73

★★★★☆4.8 (126)

The letter cited three deaths among patients using semaglutide, the active ingredient in several of its weight-loss medications, which it said were not properly investigated or reported. Read more at the link

26.86

★★★★★4.9 (98)

FLOWing with the SemagluTIDE — NephJC

27.47

★★★★★5.0 (157)

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

20.65

★★★★★4.7 (84)

FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease

22.03

★★★★★4.9 (203)

Semaglutide (#wegovy\#ozempic) was shown to reduce risk of heart attack, strokes & death in those with obesity and heart disease but this analysis confirms that the #weightloss, per se, is not the

26.06

★★★★★5.0 (176)

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

27.17

★★★★★4.8 (132)